1. Critical Analysis of the Updated Barcelona Clinic Liver Cancer (BCLC) Group Guidelines

   • Diamantis I. Tsilimigras
   • Hassan Aziz
   • Timothy M. Pawlik

   ASO Perspectives 19 July 2022 Pages: 7231 - 7234

   

2. Bridging the Disparity Gap in Surgical Oncology Access: Does Telehealth Hold a Key?

   • Elliot A. Asare
   • Michael H. Andreae
   • John H. Stewart IV

   Global Health Services Research 19 July 2022 Pages: 7235 - 7236

3. Assessment of the PARITY Sub-Analysis “Neoadjuvant Chemotherapy and Endoprosthetic Reconstruction for Lower Extremity Sarcomas: Does Timing Impact Complication Rates?”

   • Lauren Zeitlinger
   • R. Lor Randall

   Sarcoma 30 July 2022 Pages: 7237 - 7238

4. Patient-Derived Sarcoma Organoids Offer a Novel Platform for Personalized Precision Medicine

   • Adrian Sanchez-Fdez
   • Ashwyn K. Sharma
   • Jason K. Sicklick

   Translational Research 13 July 2022 Pages: 7239 - 7241

5. Optimizing Sarcopenia to Strengthen Patient Outcomes After Lung and Esophageal Surgery

   • Sadia Tasnim
   • Monisha Sudarshan

   Thoracic Oncology 30 July 2022 Pages: 7242 - 7243

6. Don’t Call It a Comeback—HIPEC for Gastric Cancer

   • Brian D. Badgwell

   Peritoneal Surface Malignancy 08 August 2022 Pages: 7244 - 7245

7. Genomic Predictors of Recurrence Patterns After Complete Resection of Colorectal Liver Metastases and Adjuvant Hepatic Artery Infusion Chemotherapy by Narayan et al.

   • Sean J. Judge
   • May Cho
   • Sepideh Gholami

   Hepatobiliary Tumors 12 July 2022 Pages: 7246 - 7247

8. Overcoming Treatment Disparities for Early-Stage Hepatocellular Carcinoma in the Veteran Population: Is the MISSION Act the Solution?

   • Robin Schmitz
   • Michael E. Lidsky

   Hepatobiliary Tumors 15 September 2022 Pages: 7248 - 7249

9. Utilization of National Cancer Institute-Designated Cancer Centers by Medicare Beneficiaries with Cancer

   • Parsa Erfani
   • Ayotomiwa Ojo
   • Miranda B. Lam

   ASO Research Letter 02 July 2022 Pages: 7250 - 7258

   

10. ‘At All Costs’: Breast Cancer Patient Responses to Cost Transparency and Communication

    • Lily A. Gutnik
    • Laura J. Fish
    • Rachel A. Greenup

    ASO Research Letter 09 July 2022 Pages: 7259 - 7260

11. Contemporary Analysis of Sentinel Lymph Node Biopsy Performance Among Patients with Clinically Localized Merkel Cell Carcinoma

    • Richard J. Straker III
    • Cimarron E. Sharon
    • John T. Miura

    ASO Research Letter 11 July 2022 Pages: 7261 - 7264

12. Avoiding Axillary Management Pitfalls After Neoadjuvant Chemotherapy

    • Betty Fan
    • Ted James

    ASO Research Letter 16 August 2022 Pages: 7265 - 7266

13. Telehealth Utilization Among Surgical Oncology Patients at a Large Academic Cancer Center

    • Alessandro Paro
    • Daniel R. Rice
    • Timothy M. Pawlik

    Global Health Services Research 27 July 2022 Pages: 7267 - 7276

    

14. ASO Author Reflections: Improving Telehealth Access and Its Implications in a Post-Pandemic Era

    • Daniel R. Rice
    • Timothy M. Pawlik

    ASO Author Reflections 18 July 2022 Pages: 7277 - 7278

15. ASO Visual Abstract: Telehealth Utilization Among Surgical Oncology Patients at a Large Academic Cancer Center

    • Alessandro Paro
    • Daniel R. Rice
    • Timothy M. Pawlik

    ASO Visual Abstract 27 August 2022 Pages: 7279 - 7280

16. Use of Palliative Interventions at End of Life for Advanced Gastrointestinal Cancer

    • Vivi W. Chen
    • Jorge I. Portuondo
    • Nader N. Massarweh

    Global Health Services Research 10 August 2022 Pages: 7281 - 7292

    

17. ASO Author Reflections: Palliative Interventions in Cancer Care Within the Last Year of Life: Unnecessary or Underutilized?

    • Vivi W. Chen
    • Nader N. Massarweh

    ASO Author Reflections 06 August 2022 Pages: 7293 - 7294

18. ASO Visual Abstract: Use of Palliative Interventions at End of Life for Advanced Gastrointestinal Cancer

    • Vivi W. Chen
    • Jorge I. Portuondo
    • Nader N. Massarweh

    ASO Visual Abstract 16 August 2022 Pages: 7295 - 7296

19. Landmark Series: A Review of Landmark Studies in the Treatment of Primary Localized Retroperitoneal Sarcoma

    • Megan Delisle
    • David Gyorki
    • Carolyn Nessim

    Sarcoma 10 September 2022 Pages: 7297 - 7311

20. Neoadjuvant Chemotherapy and Endoprosthetic Reconstruction for Lower Extremity Sarcomas: Does Timing Impact Complication Rates?

    • Aaron M. Gazendam
    • Patricia Schneider
    • Michelle Ghert

    Sarcoma 21 July 2022 Pages: 7312 - 7317

21. ASO Author Reflections: Timing of Neoadjuvant Chemotherapy in Patients with Sarcoma

    • Aaron M. Gazendam
    • Michelle Ghert

    ASO Author Reflections 26 July 2022 Pages: 7318 - 7318

22. ASO Visual Abstract: Neoadjuvant Chemotherapy and Endoprosthetic Reconstruction for Lower-Extremity Sarcomas—Does Timing Impact Complication Rates?

    • Aaron M. Gazendam
    • Patricia Schneider
    • the PARITY Investigators

    ASO Visual Abstract 16 August 2022 Pages: 7319 - 7319

23. Association Between Ageing and Short-Term Survival Outcomes in Patients Undergoing Surgery for Primary Retroperitoneal Sarcoma

    • Fabio Tirotta
    • Michael G. Fadel
    • Dirk C. Strauss

    Sarcoma 19 July 2022 Pages: 7320 - 7330

    

24. ASO Author Reflections: Retroperitoneal Sarcoma Surgery in the Elderly

    • Fabio Tirotta
    • Dirk C. Strauss

    ASO Author Reflections 18 July 2022 Pages: 7331 - 7332

25. ASO Visual Abstract: Association Between Ageing and Short-Term Survival Outcomes in Patients Undergoing Surgery for Primary Retroperitoneal Sarcoma

    • Fabio Tirotta
    • Michael G. Fadel
    • Dirk C. Strauss

    ASO Visual Abstract 29 July 2022 Pages: 7333 - 7334

26. Management of Locally Recurrent Retroperitoneal Sarcoma in the Adult: An Updated Consensus Approach from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group

    • William W. Tseng
    • Carol J. Swallow
    • the Transatlantic Australasian Retroperitoneal Sarcoma Working Group

    Sarcoma 29 June 2022 Pages: 7335 - 7348

    

27. ASO Author Reflections: Management of Locally Recurrent Retroperitoneal Sarcoma: The Balance is Tipped Towards Biology

    • William W. Tseng
    • Carol J. Swallow
    • Alessandro Gronchi

    ASO Author Reflections 28 June 2022 Pages: 7349 - 7350

    

28. Letter to Editor Referring to the Editorial by Istl et al. ‘Good Bone Structure: A Call for Stronger Design and Methodology in Disparity Studies in Orthopedic Oncology’ Discussing the Published Article: ‘Non-Private Health Insurance Predicts Advanced Stage at Presentation and Amputation in Lower-Extremity High-Grade Bone Sarcoma: A National Cancer Database Study’

    • Muhammad Umar Jawad
    • Brad H. Pollock
    • Steven W. Thorpe

    Sarcoma 25 July 2022 Pages: 7351 - 7352

29. Correction to: ASO Author Reflections: Insurance-Related Disparities in High Grade Bone Sarcoma of Lower Extremity

    • Muhammad Umar Jawad
    • Brad H. Pollock
    • Steven W. Thorpe

    Correction 15 April 2022 Pages: 7353 - 7353

30. Patient-Specific Sarcoma Organoids for Personalized Translational Research: Unification of the Operating Room with Rare Cancer Research and Clinical Implications

    • Steven D. Forsythe
    • Hemamylammal Sivakumar
    • Konstantinos I. Votanopoulos

    Translational Research 03 July 2022 Pages: 7354 - 7367

    

31. ASO Author Reflections: Sarcoma Organoids: Neutralizing the Word “Rare” in Rare Cancers

    • Steven D. Forsythe
    • Hemamylammal Sivakumar
    • Konstantinos I. Votanopoulos

    ASO Author Reflections 01 July 2022 Pages: 7368 - 7369

32. ASO Visual Abstract: Patient-Specific Sarcoma Organoids for Personalized Translational Research: Unification of the Operating Room with Rare Cancer Research and Clinical Implications

    • Steven D. Forsythe
    • Hemamylammal Sivakumar
    • Konstantinos I. Votanopoulos

    ASO Visual Abstract 15 July 2022 Pages: 7370 - 7371

33. Molecular Basis of Extramural Vascular Invasion (EMVI) in Colorectal Carcinoma

    • Swati Sonal
    • Vikram Deshpande
    • David L. Berger

    Translational Research 02 August 2022 Pages: 7372 - 7382

    

34. ASO Author Reflections: Colorectal Cancers with Extramural Vascular Invasion Are Associated with a Low Immune Microenvironment

    • Swati Sonal
    • David L. Berger

    ASO Author Reflections 05 August 2022 Pages: 7383 - 7383

35. ASO Visual Abstract: Molecular Basis of Extramural Vascular Invasion (EMVI) in Colorectal Carcinoma

    • Swati Sonal
    • Vikram Deshpande
    • David L. Berger

    ASO Visual Abstract 25 August 2022 Pages: 7384 - 7385

36. Metabolomic Analysis Reveals that SPHK1 Promotes Oral Squamous Cell Carcinoma Progression through NF-κB Activation

    • Chen-xing Hou
    • Guang-yan Mao
    • Jin-hai Ye

    Translational Research 12 July 2022 Pages: 7386 - 7399

    

37. Changes in the Gustave Roussy Immune Score as a Powerful Prognostic Marker of the Therapeutic Sensitivity of Nivolumab in Advanced Gastric Cancer: A Multicenter, Retrospective Study

    • Nobuhiro Nakazawa
    • Makoto Sohda
    • Hiroshi Saeki

    Translational Research 20 July 2022 Pages: 7400 - 7406

    

38. ASO Author Reflections: Changes in the Gustave Roussy Immune Score is an Important Biomarker for Therapeutic Sensitivity of Nivolumab in Gastric Cancer

    • Nobuhiro Nakazawa
    • Akihiko Sano
    • Hiroshi Saeki

    ASO Author Reflections 16 July 2022 Pages: 7407 - 7408

39. ASO Visual Abstract: Changes in the Gustave Roussy Immune Score as a Powerful Prognostic Marker of the Therapeutic Sensitivity of Nivolumab in Advanced Gastric Cancer: A Multicenter, Retrospective Study

    • Nobuhiro Nakazawa
    • Makoto Sohda
    • Hiroshi Saeki

    ASO Visual Abstract 06 August 2022 Pages: 7409 - 7409

40. A Translational Randomized Trial of Perioperative Arginine Immunonutrition on Natural Killer Cell Function in Colorectal Cancer Surgery Patients

    • Leonard Angka
    • Andre B. Martel
    • Rebecca C. Auer

    Translational Research 25 July 2022 Pages: 7410 - 7420

    

41. ASO Visual Abstract: A Translational Randomized Trial of Perioperative Arginine Immunonutrition on Natural Killer Cell Function in Colorectal Cancer Surgery Patients

    • Leonard Angka
    • Andre B. Martel
    • Rebecca C. Auer

    ASO Visual Abstract 01 August 2022 Pages: 7421 - 7422

42. Immune Evasion of Hepatoma Cancer Stem-Like Cells from Natural Killer Cells

    • Yuta Kimura
    • Ryouichi Tsunedomi
    • Hiroaki Nagano

    Translational Research 25 July 2022 Pages: 7423 - 7433

    

43. ASO Author Reflections: Characteristics of Immune Evasion from Natural Killer Cells in Hepatoma Cancer Stem-Like Cells

    • Yuta Kimura
    • Ryouichi Tsunedomi
    • Hiroaki Nagano

    ASO Author Reflections 26 August 2022 Pages: 7434 - 7434

44. PLXND1/SEMA3E Promotes Epithelial–Mesenchymal Transition Partly via the PI3K/AKT-Signaling Pathway and Induces Heterogenity in Colorectal Cancer

    • Kiyotaka Hagihara
    • Naotsugu Haraguchi
    • Hidetoshi Eguchi

    Translational Research 02 August 2022 Pages: 7435 - 7445

    

45. ASO Visual Abstract: PLXND1/SEMA3E Promotes EMT Partly via the PI3K/AKT Signaling Pathway and Induces Heterogeneity in Colorectal Cancer

    • Kiyotaka Hagihara
    • Naotsugu Haraguchi
    • Hidetoshi Eguchi

    ASO Visual Abstract 01 August 2022 Pages: 7446 - 7447

46. Fecal Microbes Associated with the Outcomes After Esophagectomy in Patients with Esophageal Cancer

    • Suguru Maruyama
    • Akihiko Okamura
    • Masayuki Watanabe

    Translational Research 14 July 2022 Pages: 7448 - 7457

    

47. ASO Author Reflections: Are Fecal Microbes Associated With Outcomes After Esophageal Cancer Surgery?

    • Suguru Maruyama
    • Akihiko Okamura
    • Masayuki Watanabe

    ASO Author Reflections 11 July 2022 Pages: 7458 - 7459

48. ASO Visual Abstract: Fecal Microbes Associated with the Outcomes After Esophagectomy in Patients with Esophageal Cancer

    • Suguru Maruyama
    • Akihiko Okamura
    • Masayuki Watanabe

    ASO Visual Abstract 27 July 2022 Pages: 7460 - 7461

49. Predictive Ability of the Five-time Chair Stand Test for Postoperative Pneumonia after Minimally Invasive Esophagectomy for Esophageal Cancer

    • Daisuke Kurita
    • Toru Sakurai
    • Hiroyuki Daiko

    Thoracic Oncology 08 July 2022 Pages: 7462 - 7470

    

50. ASO Visual Abstract: Predictive Ability of the Five-Time Chair Stand Test for Postoperative Pneumonia After Minimally Invasive Esophagectomy for Esophageal Cancer

    • Daisuke Kurita
    • Toru Sakurai
    • Hiroyuki Daiko

    ASO Visual Abstract 28 July 2022 Pages: 7471 - 7472